Novavax (NVAX) Total Debt Growth (1y) (2011 - 2016)
Powered by 
Analysis
Novavax (NVAX) Total Debt Growth (1y) (2011 - 2016) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 12.42% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 3.78% |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 0.00% |
| 10 | Novavax | 1.67 Bn | 949.38 Mn | 42.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | -91.64% |
| Jun 30, 2016 | -78.12% |
| Mar 31, 2016 | -69.68% |
| Dec 31, 2015 | -60.42% |
| Mar 31, 2015 | -51.49% |
| Dec 31, 2014 | -46.94% |
| Mar 31, 2014 | 1.96% |
| Dec 31, 2013 | 84.41% |
| Sep 30, 2013 | 44.05% |
| Jun 30, 2013 | 456.00% |
| Mar 31, 2013 | 312.78% |
| Dec 31, 2012 | 218.75% |
| Sep 30, 2012 | 359.41% |
| Jun 30, 2012 | 11.11% |
| Dec 31, 2011 | -20.00% |